About 1 in 5 U.S. adults say that they or someone in their household has been unable to afford drugs that were prescribed to them in the past 12 months, according to a new Gallup poll.
The survey found that 22.9 percent of U.S. adults said there had been a time in the past year when their household was unable to pay for drugs they were prescribed, up from 18.9 percent in January.
ADVERTISEMENT
The poll illustrates the struggles many Americans have paying for medication at a time when lowering drug prices is an intense subject of debate in Washington.
President TrumpDonald John TrumpLive updates on impeachment: Trump echoes Limbaugh: ‘Partisan sham’ Tim Ryan endorses Biden for president The Hill’s Morning Report – Diplomats kick off public evidence about Trump, Ukraine MORE has railed against high drug prices and has proposed some steps, including linking certain Medicare drug prices to lower ones paid in other countries, but he has not taken any major action that has gone into effect yet.
The Gallup survey finds the public is mostly negative on Trump’s performance on the issue so far, with 66 percent of adults saying he has done “not very much” or “none at all” to fight high drug prices. Twenty percent said he had done a “fair amount” and 7 percent said “a great deal.”
Speaker Nancy PelosiNancy PelosiGiuliani pens op-ed slamming ‘unprecedented’ impeachment inquiry Brindisi, Lamb recommended for Armed Services, Transportation Committees Overnight Health Care: Top health official defends contract payments to Trump allies | Vaping advocates confident Trump will turn from flavor ban | Sanders gets endorsement from nurses union MORE (D-Calif.) is pushing a sweeping bill to allow the secretary of Health and Human Services to negotiate lower prices on up to 250 drugs per year. Republicans oppose that measure, warning it would hinder the development of new treatments, but some are supporting smaller measures like a bill in the Senate from Sens. Chuck GrassleyCharles (Chuck) Ernest GrassleyOvernight Health Care: Top health official defends contract payments to Trump allies | Vaping advocates confident Trump will turn from flavor ban | Sanders gets endorsement from nurses union McConnell, GOP leaders say they won’t be watching House impeachment hearing Poll: 1 in 5 US adults report trouble affording prescription drugs MORE (R-Iowa) and Ron WydenRonald (Ron) Lee WydenOvernight Defense: Families sue over safety hazards at Army base | Lawmakers, NBA’s Enes Kanter speak out ahead of Erdoğan visit | Washington braces for public impeachment hearings Federal court rules baseless searches of travelers’ devices unconstitutional NBA’s Enes Kanter speaks out against Erdoğan ahead of White House visit MORE (D-Ore.).
Drug companies say that the problem is insurers and pharmacy benefit managers who are not passing discounts they receive on to consumers.
Click Here: liverpool mens jersey